- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 9/06 - Antiarrhythmics
Patent holdings for IPC class A61P 9/06
Total number of patents in this class: 903
10-year publication summary
|
18
|
40
|
67
|
62
|
59
|
58
|
80
|
58
|
67
|
47
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| AltaThera Pharmaceuticals LLC | 30 |
19 |
| Sanofi | 4301 |
15 |
| Novartis AG | 10262 |
13 |
| InCarda Therapeutics, Inc. | 41 |
13 |
| Gilead Sciences, Inc. | 2222 |
12 |
| Bristol-myers Squibb Company | 4742 |
11 |
| Allergan, Inc. | 2167 |
11 |
| Daiichi Sankyo Company, Limited | 1890 |
11 |
| Vertex Pharmaceuticals Incorporated | 1582 |
10 |
| Milestone Pharmaceuticals Inc. | 26 |
10 |
| Takeda Pharmaceutical Company Limited | 2712 |
9 |
| The Regents of the University of California | 20745 |
8 |
| Amarin Pharmaceuticals Ireland Limited | 271 |
8 |
| Children's Medical Center Corporation | 1959 |
8 |
| Osaka University | 3267 |
8 |
| Raqualia Pharma Inc. | 123 |
8 |
| Toa Eiyo Ltd. | 26 |
8 |
| Nissan Chemical Corporation | 2227 |
8 |
| Huyabio International, LLC | 69 |
8 |
| Nitto Denko Corporation | 8536 |
7 |
| Other owners | 698 |